There are several IL-1R1-antagonizing biological therapeutics (biologics such as anakinra or anti-IL-1β antibodies) showing correlations with substantial benefit in cerebral autoinflammatory diseases (59) or cognitive improvement in AD murine models (60). This evidence concerns the gene IL1B and Alzheimer disease.